Fengming Zhiyu
Guangdong
About Fengming Zhiyu
Fengming Zhiyu specializes in the study and development of stem cell medications, artificial organs, and the transformation of regenerative medicine technologies.
Company Facts
- Operating status: Active
- IPO status: Private
- Total funding: $1.4M
- Funding stage: Seed
- Last round: Seed (Jan 2026)
Industries & Categories
Biopharma, Medical
Canonical: https://fsome.com/organization/fengming-zhiyu-87758 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.